This ebook looks at innovations and best practice in scaling up cell and gene therapies, presented by industry leaders around the world.
Once a cell or gene therapy is proven to work, what are the steps to take it to the next level?
What are the pitfalls in scaling up manufacturing processes? What new challenges do allogeneic therapies present? How can risks be minimized?
In the next pages, we explore commercialization of cell and gene therapies, highlighting innovations and best practice presented by leading researchers around the world.
These include partnering strategies, process technologies and control considerations instrumental to large-scale manufacturing of these novel and complex therapies.
Jump to any article using the contents on the following page, or at any time using the Contents menu in the top left. There you can also download this eBook as a PDF.
Partnering with CDMOs and the steps of scaling up processes for vaccines and gene therapies.
Leading solutions in culturing, donor screening, and cryopreservation for allogeneic stem cell therapies.
A whitepaper by BIA Separations.
A journey in scaling up the world's first allogeneic injectable discogenic cell therapy.
How to mitigate risks in viral vector production for gene therapies.
Designing a robust and cost-effective “off-the-shelf” supply chain for cell therapy.
